CHAM
CABA icon

Clear Harbor Asset Management’s Cabaletta Bio CABA Stock Holding History

Clear Harbor Asset Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.6K Hold
19,500
– – ﹤0.01% 441
2026
Q1 		$52.5K Hold
19,500
– – ﹤0.01% 439
2025
Q4 		$42.7K Buy
+19,500
New +$48.3K ﹤0.01% 436

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Clear Harbor Asset Management's CABA Position: Q2 2026 in Review

Clear Harbor Asset Management held its Cabaletta Bio (CABA) position steady in Q2 2026 at 19,500 shares worth $60.6K. The position accounts for ﹤0.01% of the portfolio, ranked #441.

Clear Harbor Asset Management first reported a position in CABA in Q4 2025 and has held it in 3 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • Clear Harbor Asset Management held 19,500 shares of Cabaletta Bio worth $60.6K as of Q2 2026.
  • Clear Harbor Asset Management left its Cabaletta Bio share count unchanged in Q2 2026.
  • Cabaletta Bio made up ﹤0.01% of Clear Harbor Asset Management's portfolio in Q2 2026, its #441 holding.
  • Clear Harbor Asset Management first reported a position in Cabaletta Bio in Q4 2025 and has held it in 3 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Clear Harbor Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.